DEA lifts restrictions on GE imaging agent; Terumo invests in Dutch startup Quirem;

@FierceMedDev: ShiftLab's first device is nearing commercialization. Will it start a low-cost revolution? More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Robotic surgery aspirant receives $4M+ in equity financing. Article | Follow @VarunSaxena2

@EmilyWFierce: JAMA: Women face increased risk for second vaginal mesh surgery 10 years after implant. Article | Follow @EmilyWFierce

> The U.S. Drug Enforcement Agency (DEA) has removed the classification of DaTscan (Ioflupane I 123 injection) as a Schedule II controlled substance. GE Healthcare ($GE) markets the imaging agent used to assess the integrity of the striatal dopaminergic system via the dopamine transporter to determine if patients have essential tremor or a parkinsonian syndrome movement disorder such as Parkinson's disease. More

> Olympus has launched the CleverCut3V Distal Wireguided sphincterotome, which it said may be safer and more effective than existing options. More

> Terumo has invested an undisclosed amount in Dutch radioembolization imaging startup Quirem Medical. More

Biotech News

@FierceBiotech: FierceBiotech radio on GSK's latest setback, Kyle Bass' 'truthful irrelevancy,' and Horizon's web presence. More | Follow @FierceBiotech

@JohnCFierce: Four years after a transatlantic slapdown, Merck KGaA will once again seek cladribine OK. Article | Follow @JohnCFierce

@DamianFierce: I hereby endorse this bold, disruptive approach to the language of innovation. More | Follow @DamianFierce

> Lilly upsizes its new Cambridge, MA, R&D shop as Big Pharma crowds the neighborhood. Report

> Soon-Shiong's NantCell hauls in another $100M for immuno-oncology R&D. Story

> FDA advisers side against Purdue's new painkiller, citing dosing dangers. Article

Pharma News

@FiercePharma: USDA, poultry producers warn MN officials to expect bird flu resurgence. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sun targets Ranbaxy plant in Ireland as it prepares to trim manufacturing network. Article | Follow @EricPFierce

@CarlyHFierce: This date last year, I saved a story on my computer as "GSK Woes." So basically, not much has changed. | Follow @CarlyHFierce

> Boehringer's Ofev, chasing a Roche rival, wins backing from NICE. Story

> AstraZeneca picks up discarded Amgen plant as part of its biologics expansion. Report

> AbbVie scores FDA approval for expanded Humira label. Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.